NCT07621406
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Clinical trial condition
Lymphoma, B-Cell
Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.
1,617 public trials
340 recruiting studies
Lymphoma, B-Cell trial results
Active, Not Recruiting
Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis
NCT04742387
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Bone Diseases, +39 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Active, Not Recruiting
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
NCT04739813
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +17 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia
NCT02879695
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
- Locations
-
- Yale University New Haven, Connecticut, United States
- University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL
NCT05470777
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Active, Not Recruiting
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
NCT02003222
- Conditions
- Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, +20 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia
NCT05734495
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- Beth Israel Deaconness Medical Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
NCT05157971
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +16 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
NCT04628494
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States
- Community Health Network Cancer Center North Indianapolis, Indiana, United States
- University of Kentucky Markey Cancer Center Lexington, Kentucky, United States
- Henry Ford Health System Jackson, Michigan, United States
Active, Not Recruiting
A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
NCT07153796
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States